claim
-
Fiji High Court dismisses $7 billion COVID-19 cure patent claim against the State
An ambitious bid to secure damages over a blood-based COVID-19 cure was rejected by a high court, which upheld an earlier strike-out and closed the door on the case. The ruling highlights the legal boundaries of patent claims when dealing with naturally occurring material.